rs41548013

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001330360.2(POLA1):​c.3622G>C​(p.Asp1208His) variant causes a missense change. The variant allele was found at a frequency of 0.00705 in 1,204,526 control chromosomes in the GnomAD database, including 32 homozygotes. There are 2,709 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D1208G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0040 ( 1 hom., 132 hem., cov: 23)
Exomes 𝑓: 0.0074 ( 31 hom. 2577 hem. )

Consequence

POLA1
NM_001330360.2 missense

Scores

1
5
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 5.23

Publications

9 publications found
Variant links:
Genes affected
POLA1 (HGNC:9173): (DNA polymerase alpha 1, catalytic subunit) This gene encodes the catalytic subunit of DNA polymerase, which together with a regulatory and two primase subunits, forms the DNA polymerase alpha complex. The catalytic subunit plays an essential role in the initiation of DNA replication. [provided by RefSeq, Mar 2010]
POLA1 Gene-Disease associations (from GenCC):
  • X-linked intellectual disability, van Esch type
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • X-linked reticulate pigmentary disorder
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007820755).
BP6
Variant X-24826487-G-C is Benign according to our data. Variant chrX-24826487-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 587618.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00401 (448/111689) while in subpopulation NFE AF = 0.00705 (375/53175). AF 95% confidence interval is 0.00646. There are 1 homozygotes in GnomAd4. There are 132 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 132 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POLA1NM_001330360.2 linkc.3622G>C p.Asp1208His missense_variant Exon 32 of 37 ENST00000379068.8 NP_001317289.1 A6NMQ1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POLA1ENST00000379068.8 linkc.3622G>C p.Asp1208His missense_variant Exon 32 of 37 5 NM_001330360.2 ENSP00000368358.3 A6NMQ1

Frequencies

GnomAD3 genomes
AF:
0.00401
AC:
448
AN:
111634
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00229
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00115
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00705
Gnomad OTH
AF:
0.00199
GnomAD2 exomes
AF:
0.00396
AC:
710
AN:
179133
AF XY:
0.00369
show subpopulations
Gnomad AFR exome
AF:
0.00115
Gnomad AMR exome
AF:
0.00126
Gnomad ASJ exome
AF:
0.000135
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00139
Gnomad NFE exome
AF:
0.00704
Gnomad OTH exome
AF:
0.00452
GnomAD4 exome
AF:
0.00736
AC:
8043
AN:
1092837
Hom.:
31
Cov.:
27
AF XY:
0.00719
AC XY:
2577
AN XY:
358409
show subpopulations
African (AFR)
AF:
0.000799
AC:
21
AN:
26298
American (AMR)
AF:
0.00151
AC:
53
AN:
35100
Ashkenazi Jewish (ASJ)
AF:
0.000155
AC:
3
AN:
19336
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30090
South Asian (SAS)
AF:
0.00281
AC:
151
AN:
53688
European-Finnish (FIN)
AF:
0.00188
AC:
76
AN:
40464
Middle Eastern (MID)
AF:
0.000728
AC:
3
AN:
4120
European-Non Finnish (NFE)
AF:
0.00889
AC:
7451
AN:
837845
Other (OTH)
AF:
0.00621
AC:
285
AN:
45896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
249
499
748
998
1247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
282
564
846
1128
1410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00401
AC:
448
AN:
111689
Hom.:
1
Cov.:
23
AF XY:
0.00390
AC XY:
132
AN XY:
33881
show subpopulations
African (AFR)
AF:
0.00127
AC:
39
AN:
30731
American (AMR)
AF:
0.00229
AC:
24
AN:
10495
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3552
South Asian (SAS)
AF:
0.00115
AC:
3
AN:
2607
European-Finnish (FIN)
AF:
0.000660
AC:
4
AN:
6060
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.00705
AC:
375
AN:
53175
Other (OTH)
AF:
0.00197
AC:
3
AN:
1523
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00575
Hom.:
47
Bravo
AF:
0.00422
TwinsUK
AF:
0.00890
AC:
33
ALSPAC
AF:
0.00762
AC:
22
ESP6500AA
AF:
0.00183
AC:
7
ESP6500EA
AF:
0.00758
AC:
51
ExAC
AF:
0.00400
AC:
486

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

X-linked reticulate pigmentary disorder Uncertain:1
Aug 07, 2018
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 04, 2022
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
.;.;T
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.94
D;D;D
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.0078
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.94
.;.;L
PhyloP100
5.2
PrimateAI
Benign
0.40
T
PROVEAN
Uncertain
-3.0
D;.;D
REVEL
Benign
0.16
Sift
Uncertain
0.011
D;.;D
Sift4G
Uncertain
0.041
D;D;D
Polyphen
0.95
.;.;P
Vest4
0.059
MVP
0.46
MPC
0.98
ClinPred
0.031
T
GERP RS
4.7
Varity_R
0.47
gMVP
0.29
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41548013; hg19: chrX-24844604; API